CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project seeks to develop innovative drug candidates using messenger RNA technology to improve treatments for various eye diseases. The focus is on accelerating healing processes in damaged eye tissues to enhance patient outcomes and reduce healthcare costs.
Proper eyesight is essential for nearly all aspects of our life.
Yet, over 4 million people suffer from reduced eyesight or blindness worldwide each year (30 million blind or partially sighted in EU, 1 in 3 senior (65+) EU citizens faces sight loss).
Common reasons include glaucoma, cataract, macular degeneration, diabetic retinopathy, corneal injury and inflammation, as well as complications of surgery of the eye and physical injury.
Despite continuous improvements in treatment of various under…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
